Orthofix Medical Inc. (OFIX) analyst actions
Rating and price-target actions on OFIX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the OFIX overview →
1 measured OFIX analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial Targets | Press release | +1.15% | -0.44% |
Keep exploring
More OFIX: earnings → · SEC filings → · OFIX overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| DENTSPLY SIRONA Inc. (XRAY) | 1,226 | +0.05% | 52% |
| Sarepta Therapeutics, Inc. (SRPT) | 1,224 | -0.30% | 44% |
| IMMUNOMEDICS (IMMU) | 1,213 | -0.08% | 45% |
| Biogen Inc. (BIIB) | 1,208 | -0.01% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.